K. Cramér

发表

Renal ultrastructure, renal function, and parameters of lead toxicity in workers with different periods of lead exposure

R. Goyer, R. Jagenburg, K. Cramér, 1974, British journal of industrial medicine.

A comparative analysis between variation in 24-hour urinary creatinine output and 24-hour urinary volume

K. Cramér, H. Cramer, S. Selander, 1967 .

Serum lipids and lipoproteins in human pregnancy.

M. Aurell, K. Cramér, 1966, Clinica chimica acta; international journal of clinical chemistry.

SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS.

G. Tibblin, K. Cramér, 2009, Acta medica Scandinavica.

Incidence of Hypertension among Lead Workers: A Follow-up Study based on Regular Control over 20 years

L. Dahlberg, K. Cramér, 1966, British journal of industrial medicine.

Serum lipids and lipoproteins during long-term administration of an oral contraceptive.

M. Aurell, G. Rybo, K. Cramér, 1966, Lancet.

Serum beta-lipoprotein lipids and protein in normal subjects of different sex and age. With a note on the separation of beta-lipoproteins by chromatography on hydroxylapatite.

K. Cramér, 2009, Acta medica Scandinavica.

Characterization of β-lipoprotein isolated from hydroxylapatite columns

K. Cramér, I. Brattsten, 1961 .

Predisposing factors for lead poisoning.

K. Cramér, 2009, Acta medica Scandinavica. Supplementum.

Cholesterol and phospholipid content of human beta-lipoprotein in different lipemic states and following myocardial infarction.

K. Cramér, 1961, Journal of atherosclerosis research.

Interrelationships between lead in blood, lead in urine, and ALA in urine during lead work

K. Cramér, S. Selander, 1970, British journal of industrial medicine.

Plasma phospholipid levels and distribution in human maternal blood and in blood from the umbilical cord.

K. Cramér, O. Vikrot, 2009, Acta medica Scandinavica.

Effects on serum lipoprotein cholesterol of estrogen in combination with delta4-androstenedione, testosterone and methyl testosterone.

B. Hood, K. Cramér, 2009, Acta medica Scandinavica.

SERUM LIPIDS AND LIPOPROTEINS DURING PREGNANCY.

M. Aurell, K. Cramér, S. Pehrson, 1964, Clinica chimica acta; international journal of clinical chemistry.

Changes in serum and lipoprotein fatty acids during administration of ethyl arachidonate.

P. Bjorntorp, K. Cramér, 2009, Acta medica Scandinavica.

Determination of Lead in Blood by Atomic Absorption Spectrophotometry1

K. Cramér, S. Selander, 1968, British journal of industrial medicine.

Action of atromid on serum lipids and on β-lipoprotein lipids and protein

K. Cramér, 1963 .

Evaluation of atromid S (clofibrate) in hyperlipidemic states. Interim report.

B. Hood, G. Welin, K. Cramér, 2009, Acta medica Scandinavica.

STUDIES IN LEAD POISONING: Comparison between different Laboratory Tests

K. Cramér, S. Selander, 1965, British journal of industrial medicine.

Studies in Lead Poisoning: Oral Therapy with Penicillamine: Relationship between Lead in Blood and other Laboratory Tests

L. Hallberg, K. Cramér, S. Selander, 1966, British journal of industrial medicine.

Control of Lead Workers by Determination of Urinary δ-Aminolaevulinic Acid

K. Cramér, S. Selander, 1967 .

Detection of industrial lead poisoning.

M. K. Williams, K. Cramér, S. Selander, 1966, Lancet.

Coronary Angiographic Findings in Correlation with Age, Body Weight, Blood Pressure, Serum Lipids, and Smoking Habits

S. Paulin, L. Werkö, K. Cramér, 1966, Circulation.

Serum β-Lipoprotein Lipids and Protein in Elderly Male Survivors of Myocardial Infarction

K. Cramér, 2009 .

Agranulocytosis after Penicillamine and Antazoline

K. Cramér, S. Selander, 1965, British medical journal.